Clinical Trial Update: High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose chemotherapy with gemcitabine, busulfan, and thiotepa followed by autologous stem cell transplantation for primary c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Busulfan (Busulfex) (busulfan)
• Gemcitabine (Gemzar) (gemcitabine)
• Thiotepa (Tepadina) (thiotepa)

Snippet

Sponsor: Sichuan University | Conditions: Primary Central Nervous System Lymphoma (PCNSL) | Phase 2 | Status: RECRUITING